vs

Side-by-side financial comparison of Calumet, Inc. (CLMT) and ILLUMINA, INC. (ILMN). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Calumet, Inc.). ILLUMINA, INC. runs the higher net margin — 12.3% vs -3.6%, a 15.9% gap on every dollar of revenue. ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $103.8M).

Calumet, Inc. is a U.S.-headquartered specialty products firm that manufactures and distributes high-value hydrocarbon and specialty chemical products. Its offerings include specialty oils, lubricants, waxes, and renewable fuel solutions, serving industrial, consumer, and transportation segments across North America.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

CLMT vs ILMN — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.1× larger
ILMN
$1.1B
$1.0B
CLMT
Higher net margin
ILMN
ILMN
15.9% more per $
ILMN
12.3%
-3.6%
CLMT
More free cash flow
ILMN
ILMN
$147.2M more FCF
ILMN
$251.0M
$103.8M
CLMT

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
CLMT
CLMT
ILMN
ILMN
Revenue
$1.0B
$1.1B
Net Profit
$-37.3M
$134.0M
Gross Margin
-0.3%
66.1%
Operating Margin
-6.2%
19.2%
Net Margin
-3.6%
12.3%
Revenue YoY
4.8%
Net Profit YoY
EPS (diluted)
$-0.43
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMT
CLMT
ILMN
ILMN
Q1 26
$1.1B
Q4 25
$1.0B
$1.2B
Q3 25
$1.1B
Q2 25
$1.0B
Q1 25
$993.9M
Q4 24
$1.1B
Q3 24
$1.1B
$1.1B
Q2 24
$1.1B
$1.1B
Net Profit
CLMT
CLMT
ILMN
ILMN
Q1 26
$134.0M
Q4 25
$-37.3M
$334.0M
Q3 25
$313.4M
Q2 25
$-147.9M
Q1 25
$-162.0M
Q4 24
$186.0M
Q3 24
$-100.6M
$705.0M
Q2 24
$-39.1M
$-2.0B
Gross Margin
CLMT
CLMT
ILMN
ILMN
Q1 26
66.1%
Q4 25
-0.3%
65.5%
Q3 25
34.7%
Q2 25
-4.2%
Q1 25
-8.2%
Q4 24
65.9%
Q3 24
0.4%
69.0%
Q2 24
5.6%
64.8%
Operating Margin
CLMT
CLMT
ILMN
ILMN
Q1 26
19.2%
Q4 25
-6.2%
17.4%
Q3 25
30.0%
Q2 25
-9.8%
Q1 25
-4.9%
Q4 24
15.8%
Q3 24
-5.2%
68.6%
Q2 24
0.5%
-147.2%
Net Margin
CLMT
CLMT
ILMN
ILMN
Q1 26
12.3%
Q4 25
-3.6%
28.8%
Q3 25
29.1%
Q2 25
-14.4%
Q1 25
-16.3%
Q4 24
16.8%
Q3 24
-9.1%
65.3%
Q2 24
-3.4%
-178.8%
EPS (diluted)
CLMT
CLMT
ILMN
ILMN
Q1 26
$0.87
Q4 25
$-0.43
$2.16
Q3 25
$3.61
Q2 25
$-1.70
Q1 25
$-1.87
Q4 24
$1.16
Q3 24
$-1.18
$4.42
Q2 24
$-0.48
$-12.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMT
CLMT
ILMN
ILMN
Cash + ST InvestmentsLiquidity on hand
$125.1M
$1.2B
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$-732.7M
$2.7B
Total Assets
$2.7B
$6.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMT
CLMT
ILMN
ILMN
Q1 26
$1.2B
Q4 25
$125.1M
$1.6B
Q3 25
$94.6M
Q2 25
$110.6M
Q1 25
$123.4M
Q4 24
$93.0M
Q3 24
$34.6M
$70.0M
Q2 24
$7.0M
$74.0M
Total Debt
CLMT
CLMT
ILMN
ILMN
Q1 26
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.3B
Q4 24
Q3 24
$1.7B
Q2 24
Stockholders' Equity
CLMT
CLMT
ILMN
ILMN
Q1 26
$2.7B
Q4 25
$-732.7M
$2.7B
Q3 25
$-695.3M
Q2 25
$-1.0B
Q1 25
$-862.3M
Q4 24
$2.4B
Q3 24
$-672.2M
$2.1B
Q2 24
$-566.4M
$1.4B
Total Assets
CLMT
CLMT
ILMN
ILMN
Q1 26
$6.6B
Q4 25
$2.7B
$6.6B
Q3 25
$2.7B
Q2 25
$2.8B
Q1 25
$2.8B
Q4 24
$6.3B
Q3 24
$2.6B
$6.0B
Q2 24
$100
$6.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMT
CLMT
ILMN
ILMN
Operating Cash FlowLast quarter
$116.5M
$289.0M
Free Cash FlowOCF − Capex
$103.8M
$251.0M
FCF MarginFCF / Revenue
10.0%
23.0%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
2.16×
TTM Free Cash FlowTrailing 4 quarters
$56.6M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMT
CLMT
ILMN
ILMN
Q1 26
$289.0M
Q4 25
$116.5M
$321.0M
Q3 25
$23.5M
Q2 25
$-1.8M
Q1 25
$-29.3M
Q4 24
$364.0M
Q3 24
$-15.5M
$316.0M
Q2 24
$80.0M
Free Cash Flow
CLMT
CLMT
ILMN
ILMN
Q1 26
$251.0M
Q4 25
$103.8M
$267.0M
Q3 25
$15.1M
Q2 25
$-15.4M
Q1 25
$-46.9M
Q4 24
$335.0M
Q3 24
$-32.2M
$284.0M
Q2 24
$49.0M
FCF Margin
CLMT
CLMT
ILMN
ILMN
Q1 26
23.0%
Q4 25
10.0%
23.0%
Q3 25
1.4%
Q2 25
-1.5%
Q1 25
-4.7%
Q4 24
30.3%
Q3 24
-2.9%
26.3%
Q2 24
4.4%
Capex Intensity
CLMT
CLMT
ILMN
ILMN
Q1 26
Q4 25
1.2%
Q3 25
0.8%
Q2 25
1.3%
Q1 25
1.8%
Q4 24
2.6%
Q3 24
1.5%
3.0%
Q2 24
2.2%
2.8%
Cash Conversion
CLMT
CLMT
ILMN
ILMN
Q1 26
2.16×
Q4 25
0.96×
Q3 25
0.07×
Q2 25
Q1 25
Q4 24
1.96×
Q3 24
0.45×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMT
CLMT

Specialty Products And Solutions$675.9M65%
Montana Renewables$294.2M28%
Performance Brands$68.5M7%

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

Related Comparisons